• There are a number of characteristics of Chylobinoid® that differentiate it from CBD;
- CBDa is believed to be more potent than CBD
- Skin penetrability of Chylobinoid® cream is superior to CBD because of its coordination with the mineral magnesium
- Chylobinoid® has better absorption than CBD capsule format because Chylobinoids® are designed to bypass the liver, which acts as a filter to CBD and significantly reduces the amount of CBD that reaches the bloodstream.
In addition, Chylobinoid® is:
i) Relatively inexpensive to produce,
ii) Easily measured for accurate dosage and delivery,
iii) Designed to reduce first-pass hepatic metabolism and more than double bioavailability,
iv) Designed to contain other cannabinoid materials, which may enhance clinical efficacy through the “entourage effect”,
vi) Patentable as new compositions of matter.
According to preliminary research in this space, CBDa is reportedly more effective than CBD in the treatment of inflammation, epilepsy, nausea, pain, and some neurodegenerative diseases. Moreover, Chylobinoid® is designed to bypass the body’s hepatic metabolism—leading to greater absorption of the cannabinoid payload into the bloodstream.
Chylocure offers consumer products including creams, lotions, capsules, and also wholesale powder for manufacturers who want to formulate a variety of products with the Chylobinoid® compound.